Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Bullboard Posts
Post by Kensin1954on May 04, 2020 2:23pm
296 Views
Post# 30984582

11 MILLION SHARES

11 MILLION SHARES...So Far today.

The French Lab has no bearing on the Canadian approval.

That will be determined by availability, cost, and validity.

It seems likely this will be approved but it will be one of many.

Cuomo said yesterday the strain that came via Europe is different than the one that landed on in California, Washington State, and the Canadian midwest.

What they have in Ontario and Quebec is the same as New York as per his intel.

The number of tests required will be much more then DataMatrix can supply.

I think Tortif's question on how they will use the dollars and visibility to further the AI Heart of this company is vital.  Webinar will be a make or break from a consumer/investor perspective...   
This will either run or die based on what is said and done in the next 7 days. 

My money is still here after two years. Sometimes the stars do align even when you have made some questionable staff decisions. 

JMHO
Bullboard Posts